Latest Breaking News On - Bloomberg johnson - Page 3 : comparemela.com

J&J Seeks Backing for $11 Billion Baby Powder Cancer Deal

(Bloomberg) Johnson & Johnson will ask thousands of people suing over its allegedly tainted baby powder to vote in favor of a settlement that would allow the company to resolve all litigation for $11 billion — $2.1 billion more than it offered last year.Most Read from BloombergTesla Axes Supercharger Team in Blow to Broader EV MarketNYC Police Break Up Columbia Protest and Clashes Erupt at UCLALilly Soars as Forecast Boost Shows Weight-Loss Drugs’ PowerAmazon Posts Strongest Cloud Sales Growt

New jerseyUnited statesAndy birchfieldBloomberg johnsonErik haasBloomberg businessweekJpmorgan chase co chris schottUs district courtUs supreme courtChris schottJohnson talcum powder products marketingSales practicesProducts liability litigation

J&J, Kenvue Told to Pay $45 Million to Baby Powder User s Family

J&J, Kenvue Told to Pay $45 Million to Baby Powder User s Family
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesErik haasTheresa garciaStephanie salcedoBloomberg johnsonPatricia mattheyMelissa wittCook county circuit court chicagoCyprus amax mineralsKenvue incNorth americanBaby powderNorth americaJessica deanAmax mineralsCook county circuit court

J&J to buy Shockwave for US$13B in medical device play

J&J to buy Shockwave for US$13B in medical device play
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesSanta claraBloomberg johnsonJpmorgan securitiesShockwave medical incBoston scientific corpAmbrx biopharma incShockwave medicalCalifornia based shockwaveBoston scientificAmbrx biopharmaPerella weinberg partners

J&J s Drugs, Devices Drive Profit Above Wall Street Expectations

J&J s Drugs, Devices Drive Profit Above Wall Street Expectations
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Bloomberg johnsonKenvue incNew brunswickNew jersey based

J&J Slides as Device Margins Droop, Drug Sales Seen Falling

(Bloomberg) Johnson & Johnson shares tumbled after the company said profit margins in its medical device and technology unit fell last quarter and drug sales will be lower in the second half of the year than the first.Most Read from BloombergChina Weighs Stock Market Rescue Package Backed by $278 BillionNetflix Pays $5 Billion for ‘Raw’ in Bet on Live EventsAn Isolated Israel Doubles Down on War in Gaza — At All CostsIndia Tops Hong Kong as World’s Fourth-Largest Stock MarketHong Kong Stocks

United statesNew yorkGerry smithMizuho jared holzBloomberg johnsonJoe wolkVijay kumarBloomberg businessweekBoston scientificKenvue incBoston scientific corpAbbott laboratoriesInflation reduction actJared holzChief financial officer joe wolkNew brunswick